Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_assertion type Assertion NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_head.
- NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_assertion description "[Short term studies with dornase alfa in patients with more severe pulmonary disease (FVC < 40% of predicted value) and in those with acute infectious exacerbations did not reveal any significant improvements in pulmonary function, although long term studies are required to fully determine efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_provenance.
- NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_assertion evidence source_evidence_literature NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_provenance.
- NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_assertion SIO_000772 7533697 NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_provenance.
- NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_assertion wasDerivedFrom befree-2016 NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_provenance.
- NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_assertion wasGeneratedBy ECO_0000203 NP1311089.RAYfo5N98bd3L2d54CUMXjijMiCzhcdQW2FM6sdBtZ6OM130_provenance.